Great Basin Scientific (Great Basin Scientific) Total Liabilities : $59.11 Mil (As of Mar. 2017)

View and export this data going back to 2014. Start your Free Trial

What is Great Basin Scientific Total Liabilities?

Great Basin Scientific's Total Liabilities for the quarter that ended in Mar. 2017 was $59.11 Mil.

Great Basin Scientific's quarterly Total Liabilities declined from Sep. 2016 ($144.88 Mil) to Dec. 2016 ($129.38 Mil) and declined from Dec. 2016 ($129.38 Mil) to Mar. 2017 ($59.11 Mil).

Great Basin Scientific's annual Total Liabilities increased from Dec. 2014 ($15.58 Mil) to Dec. 2015 ($51.75 Mil) and increased from Dec. 2015 ($51.75 Mil) to Dec. 2016 ($129.38 Mil).

Great Basin Scientific Total Liabilities Historical Data

The historical data trend for Great Basin Scientific's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Great Basin Scientific Total Liabilities Chart

Great Basin Scientific Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Total Liabilities

29.68

38.39

15.58

51.75

129.38

Great Basin Scientific Quarterly Data
	Dec12	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Total Liabilities	Get a 7-Day Free Trial												71.00	87.08	144.88	129.38	59.11

Great Basin Scientific Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Great Basin Scientific's Total Liabilities for the fiscal year that ended in Dec. 2016 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	71.497	+	(15.056	+	42.831
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	129.38

Total Liabilities	=	Total Assets (A: Dec. 2016 )	-	Total Equity (A: Dec. 2016 )
	=	73.397	-	-55.986
	=	129.38

Great Basin Scientific's Total Liabilities for the quarter that ended in Mar. 2017 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	43.221	+	(0.052	+	15.834
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	59.11

Total Liabilities	=	Total Assets (Q: Mar. 2017 )	-	Total Equity (Q: Mar. 2017 )
	=	29.247	-	-29.861
	=	59.11

Great Basin Scientific Total Liabilities Related Terms

Thank you for viewing the detailed overview of Great Basin Scientific's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Great Basin Scientific (Great Basin Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Great Basin Scientific Inc (GREY:GBSNQ) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 East South Temple, Suite 520, Salt Lake City, UT, USA, 84111

Website

http://www.gbscience.com

Great Basin Scientific Inc is the United States based molecular diagnostic testing company. It is focused on the development and commercialization of molecular diagnostic platform designed to test for the infectious disease, especially hospital-acquired infections. Molecular diagnostic testing reduces test time from days to hours compared to culture methods. The company's system includes an analyzer, which it provides for the customers' use without charge in the United States, and a diagnostic cartridge, which it sells to the customers. The group derives its revenue from the sale of single-use assays sold in the United States, the European Union, and New Zealand, of which majority of the revenue is generated from the United States.

Great Basin Scientific (Great Basin Scientific) Headlines

No Headlines